Texas Permanent School Fund’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-17,635
Closed -$383K 520
2024
Q1
$383K Buy
17,635
+235
+1% +$5.84K ﹤0.01% 1493
2023
Q4
$503K Buy
17,400
+124
+0.7% +$3.32K ﹤0.01% 1469
2023
Q3
$462K Sell
17,276
-238
-1% -$8.13K ﹤0.01% 1446
2023
Q2
$649K Sell
17,514
-174
-1% -$6.07K 0.01% 1386
2023
Q1
$552K Buy
17,688
+4,428
+33% +$143K 0.01% 1402
2022
Q4
$395K Sell
13,260
-1,327
-9% -$47.5K 0.01% 1398
2022
Q3
$556K Buy
14,587
+339
+2% +$17K 0.01% 1312
2022
Q2
$777K Buy
14,248
+501
+4% +$27.5K 0.01% 1233
2022
Q1
$858K Sell
13,747
-234
-2% -$15.4K 0.01% 1251
2021
Q4
$1.41M Sell
13,981
-213
-2% -$18.7K 0.02% 1078
2021
Q3
$1.28M Buy
14,194
+1,009
+8% +$91.7K 0.02% 1126
2021
Q2
$1.22M Buy
13,185
+26
+0.2% +$2.08K 0.01% 1162
2021
Q1
$1.27M Buy
13,159
+2,634
+25% +$272K 0.02% 1125
2020
Q4
$548K Sell
10,525
-199
-2% -$8.31K 0.01% 1357
2020
Q3
$429K Buy
+10,724
New +$336K 0.01% 1367

Other funds holding FLGT

Texas Permanent School Fund's FLGT Position: Q2 2024 in Review

Texas Permanent School Fund sold out of Fulgent Genetics (FLGT) in Q2 2024, closing a stake of 17,635 shares — an estimated $383K sold.

Texas Permanent School Fund first reported a position in FLGT in Q3 2020 and held it in 15 quarters. The position peaked at $1.41M in Q4 2021. 173 funds tracked by Wall St. Rank hold FLGT as of Q2 2024.

  • Texas Permanent School Fund reported no remaining Fulgent Genetics position as of Q2 2024 after selling out during the quarter.
  • Texas Permanent School Fund sold 17,635 Fulgent Genetics shares in Q2 2024, an estimated $383K.
  • Texas Permanent School Fund first reported a position in Fulgent Genetics in Q3 2020 and held it in 15 quarters.
  • Texas Permanent School Fund's Fulgent Genetics position peaked at $1.41M in Q4 2021.
  • 173 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2024.

Based on Texas Permanent School Fund's 13F filing for Q2 2024, filed 7 Aug 2024.